Atopic Dermatitis

The inflammatory markers and leukocyte profiles detailed in the study had not been previously evaluated in any longitudinal studies.

Despite this, an increased incidence of mild to moderate oral candidiasis was also observed in the pooled data from 8 trials.

Recent research has indicated that photos of skin can be used to assess AD severity.

Investigators believe that the BPDAI may under-estimate overall disease severity in darker skin types.

The study was specific to Olmsted County, Minnesota, and was the first American population-based study examining the association between hidradenitis suppurativa and these various conditions

Though minocycline therapy has been effective in treating acne, it can often leave erythema and hyperpigmentation which can be mitigated via Intense Pulsed Light.

Dr. Christine Rauscher details immunotherapy for seasonal allergies, which affect roughly 20 millions adults in the US

Eric Simpson, MD, MCR, reviews conventional topical and systemic therapy treatment options for the management of atopic dermatitis.

Drs Eric Simpson, Alexandra K. Golant, and Raj J. Chovatiya share their approaches to atopic dermatitis care.

Previous data suggests that lower antioxidant status in early life is associated with allergic status in childhood, which implies that antioxidant use could be beneficial in the management of atopic dermatitis.

The risk of cSCC was significantly higher in patients who received treatment for actinic keratosis.

However, comorbidity risk was believed to be substantially different between the two diseases.

Raj J. Chovatiya, MD, PhD, comments on the impact of atopic dermatitis on the quality of life for patients and their families.

Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, provide an overview of the pathophysiology of atopic dermatitis and detail how to approach an atopic dermatitis diagnosis.

EPSOLAY is the first and only micro-encapsulated benzoyl peroxide topical treatment shown to improve inflammatory lesions associated with rosacea

Double board certified dermatologist Dr. Karan Lal details targeted therapies and surgical treatments for vitiligo and how the condition is perceived by different cultures.

Dr. Brett King returns to discuss the impact of JAK inhibitors in the management of atopic dermatitis.

Dr. Sarah Asch details therapeutic strategies for treating pediatric patients with vitiligo.

Key themes such as a distrust in conventional therapies and non-conventional "cures" with no scientific evidence were observed.

Elapsed time following diagnosis, naïve biologic therapy status and previous use of only 1 biologic were associated with higher persistence rates.

Cotton gloves showed superior comfort and practicability among patients with hand dermatoses.

Despite this, investigators noted that patients with ICI-induced bullous pemphigoids experienced relatively improved tumor responses.

New 108 week data found that treatment with the biologic resulted in significant skin clearance in pediatric patients with psoriasis.

The study suggested that dermatologists in academic settings were more likely to utilize teledermatology prior to the limitations of the COVID-19 pandemic as well.

New phase 3 data found that 70% of patients with atopic dermatitis achieved EASI-75 following treatment with lebrikizumab and topical corticosteroids